Business & regional news

Month Year

Month Year

Nov 2, 2022

Clinical studies show Medtronic drug coated balloon outperforms bare metal stents; maintains performance in real world

Late-breaking clinical presentations at VIVA show IN.PACT™ Admiral™ drug-coated PTA balloon catheter outperforms bare metal stents; maintains performance in real-world setting
- Peripheral Vascular Health
Oct 14, 2022

ABRE clinical study 36-month data shows sustained effectiveness of Abre™ venous self-expanding stent system

Study data show clinically meaningful impact on quality of life and disease severity, even in the most complex patients
- Peripheral Vascular Health
May 27, 2022

Medtronic low-profile drug-coated balloon platform receives U.S. FDA approval to treat peripheral arterial disease

Built on the market-leading IN.PACT™ Admiral™ DCB technology, the IN.PACT™ 018 DCB is engineered to cross tight lesions and designed for better deliverability^§
- Peripheral Vascular Health
- Photos 1
Apr 27, 2022

IN.PACT™ AV drug-coated balloon first and only to show sustained and superior performance compared to PTA through 36 months

Medtronic, the global leader in medical technology, today announced new randomized controlled data demonstrating the sustained and superior performance of IN.PACT AV drug coated balloon (DCB)...
- Peripheral Vascular Health

Show per page